TWi's sanctions bid amounts to improper summary judgment request, US judge says
MLex Summary: A California federal judge denied TWi Pharmaceuticals' motion for sanctions against plaintiffs in US antitrust litigation over a settlement agreement between the manufacturer of protein pump inhibitor Dexilant and...To view the full article, register now.
Already a subscriber? Click here to view full article